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Saturated free fatty acids (FFAs) have complex effects
on the islet b-cell, acutely promoting adaptive hyperpla-
sia but chronically impairing insulin release. The acute
effects of FFAs remain incompletely deﬁned. To eluci-
date these early molecular events, we incubated mouse
b-cells and islets with palmitate and then studied mRNA
translation by polyribosomal proﬁling and analyzed sig-
naling pathways by immunoblot analysis. We found that
palmitate acutely increases polyribosome occupancy of
total RNA, consistent with an increase in mRNA trans-
lation. This effect on translation was attributable to ac-
tivation of mammalian target of rapamycin (mTOR)
pathways via L-type Ca2+ channels but was indepen-
dent of insulin signaling. Longer incubations led to
depletion of polyribosome-associated RNA, consistent
with activation of the unfolded protein response (UPR).
Pharmacologic inhibition of mTOR suppressed both the
acute effects of palmitate on mRNA translation and the
chronic effects on the UPR. Islets from mice fed a high-
fat diet for 7 days showed increases in polyribosome-
associated RNA and phosphorylation of S6K, both
consistent with activation of mTOR. Our results sug-
gest that palmitate acutely activates mRNA translation
and that this increase in protein load contributes to the
later UPR.
Consumption of foods high in saturated fat is associated
with obesity and insulin resistance. Obese, “metabolically
healthy” individuals maintain normoglycemia in the face
of insulin resistance by augmenting insulin release from
islet b-cells. Failure to maintain the necessary state of
augmented b-cell mass and/or function leads to the de-
velopment of type 2 diabetes (1,2). The speciﬁc signals
that cause the initial increases in b-cell mass and func-
tion in obesity and the later loss of these parameters in
type 2 diabetes have not been entirely elucidated, but
hormonal and cytokine signals emanating from distant
sources such as the liver and bone have been variably
implicated (3–6). In addition to these organ-derived sig-
nals, diet-derived factors such as free fatty acids (FFAs)
have also been shown to directly impact b-cell responses
(6,7). FFAs appear to have a duality of effects on the
b-cell, either augmenting in the short-term or limiting
in the long-term insulin release and cellular replication
(7–9).
The molecular mechanisms underlying the dichoto-
mous responses of the b-cell to FFAs have not been fully
elucidated. It has been postulated that the effect of FFAs
to augment b-cell function (i.e., glucose-stimulated insulin
secretion) may be important for the early hypersecretion
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of insulin seen in insulin resistance. This effect of FFAs
is thought to occur via several mechanisms. One is
through the interaction of FFAs with FFA receptor 1
(GPR40), which signals through Gaq/11 to augment
glucose-stimulated insulin secretion (10,11). A second
mechanism is through the cellular metabolism of FFAs (to
generate lipid-derived signaling molecules) and glycerolipid/
FFA cycling (12). More recently, elegant studies of Zarrouki
et al. (6) suggest growth-promoting effects of FFAs in
rats in vivo may in part be secondary to growth factor
signaling and activation of mammalian target of ra-
pamycin (mTOR). Studies have also shown deleterious
effects of FFAs on b-cell function, a ﬁnding that is
thought to be a more chronic effect and that is fre-
quently observed in the presence of hyperglycemia
(“glucolipotoxicity”). It has been suggested that these
lipotoxic effects on the b-cell are mediated in part by
endoplasmic reticulum (ER) stress (13–15). However, the
speciﬁc mechanisms by which saturated FFAs inﬂuence ER
protein load and mRNA translation in the b-cell have never
been investigated.
In this study, we sought to clarify the effect and
mechanisms of the major circulating saturated FFA
palmitate on mRNA translation in a mouse b-cell line and
isolated mouse islets. Polyribosome proﬁle (PRP) analysis
during short- and long-term incubations revealed that
palmitate acutely triggers mRNA translation via mTOR
and increases ER protein load; longer incubations caused
activation of the ER stress cascade and a block in mRNA
translational initiation. Our results suggest a model
whereby the activation of mTOR in a dose-dependent
manner by palmitate in b-cells may contribute to an early
hyperplastic response, and that these effects impose in-
creased protein load on the ER, activating the unfolded
protein response (UPR) in the long-term.
RESEARCH DESIGN AND METHODS
Animals
Male C57BL/6J mice were purchased from The Jackson
Laboratory. All mouse experiments were approved by the
Indiana University Institutional Animal Care and Use
Committee. Eight-week-old mice were fed a rodent diet
containing either 10 or 60% kcal from fat (Research Diets
D12450B or D12492, respectively). Glucose tolerance tests
in mice were performed after 6 days of diet using 2 g/kg
glucose injected intraperitoneally (16). Body composition
was measured using DEXA after 6 days of diet using a
PIXImus DEXA scanner. Mouse islets were isolated from
8-week-old chow-fed animals as previously described (17).
Antibodies
Antibodies were commercially acquired as follows: p-Akt
(Thr308) (no. 4056; Cell Signaling Technology), p-Akt
(Ser473) (no. 9271; Cell Signaling Technology), Akt (no.
2920; Cell Signaling Technology), p-4E-BP1 (Thr70) (no.
9455; Cell Signaling Technology), p-p70 S6K (Thr389)
(no. 9206; Cell Signaling Technology), p70 S6K (no. 2708;
Cell Signaling Technology), p-eIF2a (no. 9721; Cell Signal-
ing Technology), b-actin (no. 691002; MP Biomedicals),
4E-BP1 (sc-6024; Santa Cruz Biotechnology), and eIF2a
(sc-133132; Santa Cruz Biotechnology). Fluorophore-
labeled secondary antibodies IRDye 800 and IRDye 700
were from LI-COR Biosciences.
Cell Isolation and Culture
MIN6 b-cells, b-cell insulin receptor knockout (bIRKO)
cells, and LOX cells were maintained in 25 mmol/L glu-
cose as previously described (18). On the evening prior to
experimentation, cells were incubated in medium contain-
ing 5.5 mmol/L glucose, and on the morning of experi-
mentation, glucose concentration was increased to 20
mmol/L. Mouse islets were cultured in 11 mmol/L glucose
as previously described (16) and were allowed to recover
overnight prior to experimentation. Human islets were
obtained from the Integrated Islet Distribution Program
and cultured in 11 mmol/L glucose as previously de-
scribed (19). For PRP experiments, islets were transferred
into cold RPMI medium containing 5 mmol/L glucose
after isolation and used immediately. Sodium palmitate,
sodium oleate, fatty acid–free BSA, thapsigargin, wortman-
nin, and rapamycin were purchased from Sigma-Aldrich.
Torin1 was from Tocris Bioscience. FFA and fatty acid–
free BSA conjugates (at an 8:1 molar ratio of FFA to BSA,
unless otherwise stated) were prepared as described pre-
viously (20). Control cells were identically treated in terms
of glucose concentrations and timing of inhibitors, except
that BSA was added without FFA.
PRP and RT-PCR Experiments
PRP experiments using MIN6 cells and islets proceeded as
described previously (21,22), wherein cell lysates were
passed through a 10–50% sucrose gradient and fraction-
ated using a BioComp piston gradient fractionator. RNA
absorbance at 254 nm was recorded using an in-line UV
monitor, and fractions were collected. Total RNA from the
fractions was reverse transcribed and subjected to quan-
titative real-time PCR. Polysome-to-monosome (P/M) ra-
tios were quantitated by calculating the area under the
curve corresponding to the polyribosome peaks (more
than two ribosomes) divided by the area under the curve
for the monosome (80S) peak. Reverse-transcribed RNA
was analyzed by real-time PCR using SYBR Green I-based
methodology (23). Primers for Bip, Xbp1, spliced Xbp1,
Chop, Atf4, Pcna, Ki67, and Tbp were described previously
(24–27). All samples were corrected for input RNA by
normalizing to Tbp message.
Immunoblot Analysis
Whole-cell extracts from MIN6 cells and mouse islets
were prepared as described previously (28). Immunoblot
analyses of MIN6 cells and islet extracts were performed
after resolution of protein extracts by 4–20% gradient
SDS-PAGE. Immunoblots were visualized using ﬂuores-
cently labeled secondary antibodies (LI-COR Biosciences)
and were quantiﬁed using LI-COR software.
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35S-Met/Cys Incubation Studies
MIN6 cells or mouse islets were cultured in 12-well plates
in the presence or absence of palmitate or cycloheximide
for 1 h. For the pulse label, the cells or islets were washed
and incubated with culture media lacking Met and Cys,
supplemented with 125 mCi of a mixture of 35S-Met and
35S-Cys (PerkinElmer) for the ﬁnal 15 min of the incubation.
Cellular lysates were loaded on a 10% SDS-polyacrylamide
gel and subjected to electrophoresis. The gel was dried and
exposed to X-ray ﬁlm overnight and quantitated using
ImageJ Software (National Institutes of Health).
Statistical Analyses
All data are presented as the mean 6 SEM. Statistical
signiﬁcance of differences between two groups was eval-
uated using a two-tailed Student t test. Prism 5 software
was used for all statistical analyses. Statistical signiﬁcance
was assumed at P , 0.05.
RESULTS
Chronic Palmitate Incubation Reduces Polyribosome-
Associated RNAs in b-Cells
To study mRNA translation, we used PRP analysis. PRP
analysis involves the isolation of total cellular RNA and
then subjecting the RNA to sedimentation through
a sucrose gradient, which separates RNAs based on the
nature and number of associated ribosome units (29,30).
The normal PRP of MIN6 b-cells is shown in Fig. 1A (solid
line), which identiﬁes the positions of 40S and 60S ribosome-
associated RNAs, as well as monoribosome (80S)- and poly-
ribosome (more than two monoribosomes)-associated RNA
species. To study the effects of saturated FFAs on mRNA
translation in b-cells, we incubated MIN6 b-cells with 0.5
mmol/L palmitate (at an 8:1 molar ratio of palmitate to
BSA)/20 mmol/L glucose and subsequently performed PRP
analysis. Within 1 h of palmitate addition, there was an
increase in the fraction of RNAs associated with polyribo-
somes (Fig. 1A, dashed line), which was reﬂected by an in-
creased P/M ratio (Fig. 1A). The P/M ratio subsequently
normalized by 24 h of palmitate incubation (Fig. 1B), and
by 72 h of incubation, a decrease in the P/M ratio was
observed (Fig. 1C).
Decreases in P/M ratios are characteristically associ-
ated with the UPR, wherein relative reductions in trans-
lation initiation, a result of phosphorylation of eukaryotic
translation initiation factor 2a (eIF2a), cause “runoff” of
ribosomes (29). As shown in Fig. 1D, palmitate incubation
of MIN6 cells led to increases in phospho-eIF2a (p-eIF2a)
with time. Interestingly, the basal level of p-eIF2a also
increased with increasing time of incubation, suggestive
of an effect of cellular growth. Incubation of MIN6 b-cells
for 4 h with 1 mmol/L thapsigargin, a very potent inducer
of p-eIF2a and the UPR, resulted in a similar (though
more dramatic) reduction in the P/M ratio (Fig. 1E), ac-
companied by increased p-eIF2a (Fig. 1F). The results in
Fig. 1 collectively indicate that palmitate causes a progres-
sive reduction in global translation initiation that is con-
sistent with activation of the UPR.
Acute Palmitate Incubation Leads to Activation of the
mTOR Pathway to Promote mRNA Translation
Although the decreased P/M ratio after 72 h palmitate
incubation was consistent with activation of the UPR, the
increase in P/M ratio observed at 1 h was unexpected and
suggestive of a different process. Increases in P/M ratios can
be caused by either an increase in total mRNA translation
(i.e., an increase in global or selected protein synthesis) or by
a block in mRNA elongation (31,32). To distinguish these
possibilities, we performed 35S labeling of proteins in MIN6
cells and mouse islets treated with palmitate. As shown in
Supplementary Fig. 1A and B, 35S incorporation into total
protein was unchanged (though a tendency to increase) in
MIN6 cells and mouse islets, respectively, treated with
palmitate for 1 h. By contrast, treatment of cells with
cycloheximide (an inhibitor of translation elongation) com-
pletely blocked 35S incorporation in both cell types (Sup-
plementary Fig. 1A and B). These results suggest that the
increased P/M ratios in response to palmitate are not
caused by translational blockade, but more likely from in-
creased mRNA translation.
mTOR exists as two distinct protein complexes (mTOR
complex 1 and complex 2 [mTORC1 and mTORC2]) that
couple the sensing of the nutritional/energy status of
the cell to protein synthesis and growth (33). We tested
the possibility that palmitate activates mTOR com-
plexes to enhance mRNA translation. As shown in Fig.
2A, incubation of MIN6 cells for 1 h with increasing
concentrations of palmitate (0.1–0.5 mmol/L) led to
increasing phosphorylation of two major translation-
promoting targets of mTORC1, S6 kinase (S6K) at
T389 and eIF4E binding protein 1 (4E-BP1) at T70. In
accordance with a causative role of the mTOR pathway in
palmitate-induced increases in mRNA translation, Fig.
2B and C show that coincubation with palmitate and
the mTORC1 inhibitor rapamycin or with the mTORC1/2
inhibitor Torin1 resulted in reversal of the palmitate-
induced increase in polyribosome-associated RNAs in
MIN6 cells.
Activation of mTORC1 by Palmitate Is Mediated
Through the Phosphoinositide-3 Kinase/Akt Pathway
To interrogate the signaling mechanisms linking acute
palmitate effects to mTORC1/2 activation, we next
assessed the phosphoinositide-3 kinase (PI3K)/Akt path-
way. Figure 3A and B show that palmitate acutely acti-
vates Akt in MIN6 cells and mouse islets within 1 h, as
reﬂected by phosphorylation of Akt residues T308 and
S473. These Akt phosphorylation events (and, indeed,
even basal levels of phosphorylation) were abrogated by
the selective PI3K inhibitor wortmannin but not by the
selective mTORC1 inhibitor rapamycin (Fig. 3A and B),
a result consistent with an upstream dependency of Akt
activation on PI3K. The mTORC1/2 inhibitor Torin1
blocked the Akt phosphorylation events in MIN6 cells,
in agreement with prior observations that mTORC2 lies
upstream of Akt phosphorylation (34).
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Major downstream effects of mTORC1 action include
the phosphorylations of S6K and 4E-BP1, events that
promote mRNA translation (33). As shown in Fig. 3C and
D, palmitate incubation led to phosphorylations of S6K
and 4E-BP1 within 1 h. These phosphorylation events
were blocked by wortmannin, rapamycin, and Torin1
(Fig. 3C and D), placing the effects of palmitate on S6K
and 4E-BP1 downstream of mTOR signaling. Importantly,
Figure 1—Acute and chronic effects of palmitate on mRNA translation. A: PRP analysis (left panel) and associated P/M ratio (right panel) of
MIN6 cells after incubation under control (CTL) or palmitate (PAL, 0.5 mmol/L) conditions for 1 h. Numbers above the peaks indicate
numbers of ribosomes. B: PRP analysis (left panel) and associated P/M ratio (right panel) of MIN6 cells after incubation under control and
palmitate conditions for 24 h. C: PRP analysis (left panel) and associated P/M ratio (right panel) of MIN6 cells after incubation under control
and palmitate conditions for 72 h. D: Representative immunoblot (top panel) and corresponding quantitation (from n = 4) (bottom panel) of
p-eIF2a and total eIF2a after incubation of MIN6 cells with control or palmitate for the indicated times. E: PRP analysis (left panel) and
associated P/M ratio (right panel) of MIN6 cells after incubation under control and thapsigargin (Tg, 1 mmol/L) conditions for 4 h. F:
Representative immunoblot (top panel) and corresponding quantitation (from n = 4) (bottom panel) for p-eIF2a and total eIF2a after
incubation of MIN6 cells with control or thapsigargin for 4 h. In all panels, control cells were incubated at the same glucose concentrations
as palmitate-treated cells, and BSA was added in place of palmitate-BSA conjugates. Quantitative data represent mean 6 SEM of at least
three independent determinations. *P < 0.05.
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the effects of palmitate on S6K and Akt phosphorylation
events were also observed in isolated human islets (Sup-
plementary Fig. 1C). Additionally, the effects of palmitate
on Akt and S6K phosphorylations and on the PRP in
MIN6 cells occurred at a lower molar ratio of palmitate
to BSA (5:1), and the effects on the PRP were also ob-
served (but with lower magnitude) at a 2.5:1 molar ratio
(Supplementary Fig. 2A–C). Supplementary Fig. 2C and D
show that phosphorylations of Akt and S6K, and their
downstream effects on the PRP, were also seen at low
glucose concentrations (3 mmol/L).
To determine if the effects on mTOR activation are
speciﬁc to saturated FFAs, we performed experiments using
the monounsaturated FFA oleate. As shown in Fig. 4A and
B, 0.5 mmol/L oleate caused no signiﬁcant increase in S6K
phosphorylation and a reduced phosphorylation of Akt
(S473) compared with palmitate. Consistent with these
ﬁndings, oleate did not alter the P/M ratio in the PRP
(Fig. 4C).
Palmitate Activation of mTOR Is Independent of Insulin
Signaling but Dependent Upon L-Type Calcium
Channels
To interrogate the mechanisms linking saturated FFAs to
activation of PI3K/Akt/mTOR, we next examined the
insulin signaling pathway, a major growth factor pathway
known to activate mTOR. We performed experiments
using a bIRKO cell line described previously (35). Figure
5A conﬁrms the knockout of the insulin receptor in the
bIRKO line (upper panel) and shows that palmitate still
induced Akt (S473) and S6K phosphorylations in bIRKO
cells (lower panels). These ﬁndings were also conﬁrmed in
the absence of serum in the medium (data not shown).
Together, these ﬁndings suggest that palmitate activation
of mTOR in vitro does not involve insulin signaling or
signaling by other growth factor components in the serum.
Palmitate mobilizes intracellular Ca2+, and Ca2+/
calmodulin has been shown to activate the p85 subunit
of PI3K (36). Figure 5B and C show that palmitate-
induced phosphorylation of Akt (T308 and S473) and
S6K in MIN6 cells is blocked by the L-type Ca2+ channel
blocker nifedipine. By contrast, nifedipine does not block
the same phosphorylation events induced by insulin. These
data suggest that the activation of the PI3K/Akt/mTOR
pathway by palmitate is dependent upon ﬂux through
L-type Ca2+ channels.
Activation of mTOR by Palmitate Precedes and
Contributes to the UPR
Saturated FFAs activate the UPR, leading to ER stress and
b-cell dysfunction (13). Because the UPR is triggered in
part by increased ER protein load, we asked if the activa-
tion of the mTOR pathway by palmitate temporally and
causally precedes the UPR. As shown in Fig. 6A, mRNA
parameters of UPR activation, including spliced Xbp1, Bip,
Atf4, and Chop are increased at 72 h after palmitate in-
cubation in MIN6 cells (trending similarly with 4 h of
thapsigargin incubation). A feature of the UPR is the ac-
tivation of translation initiation of Atf4 mRNA, wherein
Atf4 mRNA is actively engaged by ribosomal translational
machinery to increase ATF4 protein levels (37). Figure 6B
shows that the positioning of the Atf4 mRNA is unaltered
in the PRP of MIN6 cells treated with palmitate for 1 h.
By contrast, Fig. 6C shows that Atf4 mRNA shifts from
Figure 2—Palmitate activates mTOR signaling. A: Representative immunoblot for the indicated proteins after incubation of MIN6 cells
under control (CTL) or with varying concentrations of palmitate (PAL) for 1 h. B: Representative PRP analysis of MIN6 cells after incubation
under control, palmitate (0.5 mmol/L), or palmitate + rapamycin (Rapa, 50 nmol/L) conditions for 1 h. C: Representative PRP analysis of
MIN6 cells after incubation under control, palmitate (0.5 mmol/L), or palmitate + Torin1 (Torin, 250 mmol/L) conditions for 1 h. In all panels,
control cells were incubated at the same glucose concentrations as palmitate-treated cells, and BSA was used in place of palmitate-BSA
conjugates.
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Figure 3—Palmitate activates mTOR via PI3K/Akt. MIN6 cells (left panels) and mouse islets (right panels) were incubated under control (C),
palmitate (P, 0.5 mmol/L), or palmitate + inhibitor conditions for 1 h (MIN6) or 30 min (islets), and then subjected to immunoblot analysis for
the indicated proteins. Inhibitors are wortmannin (Wort., 200 nmol/L), rapamycin (Rapa., 50 nmol/L), and Torin1 (250 nmol/L). A: Immunoblot
for p-Akt (T308) and Akt. B: Immunoblot for p-Akt (S473) and Akt. C: Immunoblot for p-S6K and actin. D: Immunoblot for p-4E-BP1 and
actin. n = 3–6. *P < 0.05 compared with control conditions. CTL, control; PAL, palmitate.
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relative monosome fractions to polysome fractions in re-
sponse to 72-h incubation with palmitate, in a manner
similar to that seen with thapsigargin treatment (Fig. 6D).
We hypothesized that blockade of mTOR would
reduce the protein load upon the ER in response to
saturated FFAs, and thereby reduce the propensity to
trigger the UPR. To test this hypothesis, we performed
studies using the mTORC1/2 inhibitor Torin1. As shown
in Fig. 7A and B, when MIN6 cells are treated with pal-
mitate in the presence of Torin1, phosphorylation of
eIF2a at 4 h is blocked, as is the later increase in UPR-
related genes (Chop, Atf4, Bip, and Xbp1s) at 10 h. Sim-
ilar inhibition of palmitate-induced UPR gene activation
with Torin1 was also observed in mouse islets (Fig. 7C).
Figure 4—Oleate does not activate mTOR signaling. MIN6 cells were incubated under control (CTL), palmitate (PAL, 0.5 mmol/L), or oleate
(OLE, 0.5 mmol/L) for 1 h. A: Representative immunoblot (top panel) and corresponding quantitation (from n = 6) (bottom panel) of p-Akt
(S473) and Akt. B: Representative immunoblot (top panel) and corresponding quantitation (from n = 3) (bottom panel) of p-S6K and S6K. C:
Representative PRP analysis of MIN6 cells after incubation under control and oleate conditions for 1 h. *P < 0.05 for the value compared
with the corresponding control conditions.
Figure 5—Palmitate activation of mTOR is not dependent on insulin signaling but requires L-type Ca2+ channels. A: The bIRKO cell line was
incubated under control (CTL) or palmitate (PAL, 0.5 mmol/L) conditions at 20 mmol/L glucose, and then subjected to immunoblotting for
the proteins indicated. Upper panel shows representative immunoblot of control (LOX cells) and bIRKO cells for insulin receptor (IR). Lower
panel shows two independent immunoblots in bIRKO cells. B: Representative immunoblots from MIN6 cells treated under CTL, insulin (INS,
200 nmol/L), or PAL (0.5 mmol/L) conditions, with or without nifedipine (Nifed, 10 mmol/L). C: Quantitation of the immunoblot data (for n = 4)
from B. *P < 0.05 for the comparison. C, control; P, palmitate.
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High-Fat Feeding of C57BL/6J Mice Increases
Phosphorylation of Akt and S6K in Islets and Increases
mRNA Translation
To study the physiological relevance of mTOR activation
in vivo, we examined the short-term effects of a high-fat
diet (HFD; 60% kcal from fat, mostly saturated fat) versus
a low-fat diet (LFD; 10% kcal from fat) on mouse islets.
Prior studies showed that 60% HFD feeding for 1 week
increased b-cell replication and mass (27). As shown in
Fig. 8A and B, respectively, 1 week of HFD feeding led to
increases in body weight and fat mass compared with
animals on an LFD. Figure 8C shows that glucose toler-
ance was worsened upon HFD feeding (when glucose
was administered intraperitoneally based on total body
weight). Islets from HFD-fed mice revealed increases in
phosphorylations of Akt (T308) and S6K, but without
changes in phosphorylation of eIF2a (Fig. 8D). In accor-
dance with the activation of mTOR and mRNA transla-
tion, islets from HFD-fed mice displayed an increase in
genes encoding proteins involved in proliferation (Ki67
and Pcna) and an increase in the P/M ratio in PRP analysis
(Fig. 8E and F). These results suggest that 1 week of HFD
feeding may be more akin to the short-term incubations
of isolated cells with palmitate.
DISCUSSION
By use of PRP analysis, we show that b-cells acutely re-
spond to saturated FFAs (typiﬁed by palmitate) by in-
creasing association of RNA species with polyribosomes,
a process reﬂective of increased mRNA translation. The
increased mRNA translation in response to palmitate
emanates from activation of the mTOR pathways, which
link nutrient sensing to cellular growth. The growth and
function-promoting effect of saturated FFAs on b-cells
has been the topic of studies in both humans and rodents.
In adult humans, short-term (,24 h) elevations in FFA
levels (via intralipid infusions) result in exaggerated glucose-
stimulated insulin secretion (38–40). In rats, elegant studies
by Poitout and colleagues (6,8) showed that 6-month-old
rats receiving just 72 h of intralipid infusion exhibit
;50% expansion in b-cell mass that was attributed to
enhanced mTOR signaling and b-cell replication. These
latter studies suggest that mTOR may be a crucial path-
way in response to FFA signaling.
The mTOR complexes (mTORC1 and mTORC2) are
sensors of ambient nutritional status and link growth
factor signaling and availability of nutrients to protein
synthesis and cellular proliferation and size in b-cells and
other cell types (33). Of the two complexes, mTORC1 is
characterized better in b-cells. mTORC1 includes mTOR,
Raptor, and mLST8 and is sensitive to inhibition by rapa-
mycin. Secondary activation of mTORC1 by expression of
constitutively active Akt levels in b-cells increases cell
expansion and results in enhancement of cell cycle pro-
teins (41). Major downstream effects of mTORC1 activa-
tion are the phosphorylations of S6K and 4E-BP1. These
events are seminal triggers of global translational initia-
tion and elongation of mRNAs, which promote accrual of
Figure 6—Activation of the UPR by palmitate. A: MIN6 cells were incubated under control (C) or palmitate (P, 0.5 mmol/L) conditions for 1
or 72 h or with thapsigargin (Tg, 1 mmol/L) for 4 h, and then subjected to RT-PCR for the indicated genes (n = 4 independent determi-
nations). MIN6 cells were treated under control or palmitate conditions for 1 (B) and 72 h (C ) or under control and thapsigargin conditions for
4 h (D), and then subjected to PRP analysis followed by real-time RT-PCR for Atf4 of fractions from the PRP (n = 3 independent
determinations). The shaded regions in B–D show the representative PRP, and the lines represent mRNA levels. *P < 0.05 for the value
compared with the corresponding control value in all panels. CTL, control; PAL, palmitate.
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b-cell size and number (33). Our studies are the ﬁrst to show
that palmitate acutely induces an increase in polyribosome-
associated RNAs in b-cells, a ﬁnding consistent with
an increase in global mRNA translation. This effect of
palmitate is concordant with an increased activity of the
PI3K/Akt signaling pathway and the phosphorylations of
S6K and 4E-BP1. We note that the effect of palmitate on
global mRNA translation is dependent upon the fraction
of free palmitate, since lower palmitate-to-BSA ratios
have attenuated effects. Because inhibitors of mTORC1
appear to completely block S6K and 4E-BP1 phosphoryla-
tion events and polyribosome-associated RNA increases,
we propose that a direct effect of saturated FFAs is to
activate mTOR signaling. The linkage between saturated
FFAs, mTOR, and mRNA translation is supported by re-
cent studies in rats in vivo, which revealed that rapamycin
blocks the increase in b-cell mass, size, and proliferation
in response to intralipid infusion in rats (6). Our studies
in 1 week HFD-fed mice also support a role for FFAs
activating mRNA translation in islets in vivo.
In contrast to the increases in polyribosome-associated
RNAs with acute palmitate incubation, more prolonged in-
cubations resulted in reductions in polyribosome-associated
RNAs. Such reductions are suggestive of a decline in
Figure 7—Inhibition of mTOR inhibits activation of the UPR by palmitate. A: Representative immunoblot (left panel) of p-eIF2a and eIF2a
from MIN6 cells under control (CTL) and palmitate (PAL, 0.5 mmol/L) conditions with or without Torin1 (250 nmol/L) for 4 h, with
corresponding quantitation (n = 6) (right panel) of the immunoblots. C, control; P, palmitate. B: Real-time RT-PCR data from MIN6 cells
under control and palmitate conditions with or without Torin1 for 10 h. C: Real-time RT-PCR data from mouse islets under control and
palmitate conditions with or without Torin1 for 10 h. All data represent mean6 SEM of at least three independent determinations. *P< 0.05
for the value compared with the corresponding control.
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translation initiation rate relative to elongation rate,
resulting in a paucity of ribosomes associated with RNA
(29). In agreement with these ﬁndings, we observed the
onset of the UPR, in which p-eIF2a blocks general (cap-
dependent) mRNA translation. The induction of the UPR by
palmitate has been observed in a number of studies and
has been variably attributed to several processes, including
derangement of cellular calcium homeostasis, induction of
mitochondrial oxidative stress, posttranslational modiﬁca-
tion of proteins, and inhibition of splicing factors and
transcription factors (13,42–44). An important factor
that contributes to UPR and eventual ER stress is increased
protein load on the ER (45,46). Because we found an early
increase in mTOR activation and mRNA translation with
palmitate incubation, we tested the possibility that this
early increase might contribute to later induction of the
UPR. Accordingly, inhibition of mTOR with Torin1 blocked
the increase in p-eIF2a levels and Bip, spliced Xbp1, and
Chop mRNA levels. These results temporally link the early
increase in mRNA translation with the later development
of ER stress. However, the contribution of ER protein syn-
thesis versus other effects of mTOR is unclear from our
studies; we note that other studies have linked Torin1
treatment with increases in autophagy, a process that could
also help to mitigate ER stress (47).
Activation of the PI3K/Akt/mTOR pathway is linked to
growth factor signaling and/or nutrient (e.g., glucose,
amino acid) abundance. Although palmitate can acutely
Figure 8—Activation of mTOR signaling in islets of HFD-fed mice. C57BL/6J mice (n = 10 per group) were fed an LFD (10% kcal from fat) or
HFD (60% kcal from fat) for 7 days. A: Body weight of mice. B: Fat mass of mice, as determined by DEXA analysis. C: Results of glucose
tolerance test (left panel) and corresponding area under the curve (AUC) analysis (right panel). D: Results of immunoblot analysis for the
indicated proteins from islets isolated from LFD- and HFD-fed mice (n = 3 mice per group) and corresponding quantitations. E: Results of
RT-PCR analysis from islets isolated from LFD- and HFD-fed mice (n = 3 mice per group) for the Ki67 and Pcna genes. F: Representative
PRP analysis and corresponding P/M ratio (n = 3 mice per group) of islets isolated from LFD- and HFD-fed mice. For all panels, *P < 0.05
for the HFD compared with the LFD.
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augment insulin secretion in the presence of glucose, we
show that insulin signaling does not account for mTOR
activation, since the phenomenon is observed in b-cells
lacking insulin receptor. Studies of Poitout and colleagues
(6) suggest that EGF signaling in response to intralipid/
glucose infusion in rats is important in the activation of
mTORC1 in b-cells, a possibility that may be more rele-
vant in vivo. In this regard, we note that the intralipid
infusions use mixtures of saturated and unsaturated
FFAs, which likely activate release of growth factors
from other organs, secondarily affecting b-cell growth
(3,4). We cannot rule out the possibility in our high-fat
feeding studies in vivo that mTOR activation may have
been an indirect consequence of FFAs.
Some prior studies have implicated a role for FFAs in
activating mTOR. In hepatocytes, FFAs were shown to
increase mTOR signaling, but in an inverse relationship
with Akt phosphorylation. In those studies, it was felt
that mTOR activation by FFAs leads to insulin resistance
(whereas inhibition of mTOR by metformin reduces it)
(48). By contrast, studies in cell-free systems suggest that
palmitate inhibits protein tyrosine phosphatase 1B, re-
sulting in increases in Akt phosphorylation (49). Our
studies in b-cells point to a role for L-type Ca2+ channels
in the activation of Akt. Palmitate acutely increases in-
tracellular Ca2+ in human and mouse b-cells (50), and
increases in intracellular Ca2+, via calmodulin, have been
shown to associate with and activate PI3K (51). What
remains unclear is how precisely palmitate is linked to
L-type Ca2+ channels, and links to FFA transporters (e.g.,
CD36) and receptors (e.g., GPR40) remain possibilities.
Our results suggest a model whereby palmitate induces
pathways that promote increased mRNA translation and
ER workload in the b-cell. This early effect of palmitate
appears to contribute to activation of the UPR, which
when prolonged, can lead to b-cell apoptosis. We acknowl-
edge some limitations to our studies, the most notable
that they involve effects of a single saturated FFA on cells
cultured in vitro. Effects in vivo likely are more complex
and involve mixtures of FFAs and signaling from different
organs. Nevertheless, our studies identify an important
effect of palmitate on a key b-cell pathway that has here-
tofore been unappreciated. Future studies focusing on
conditional knockouts of mTOR signaling molecules in
mice will allow for more deﬁnitive conclusions in vivo
on the role of mTOR in FFA signaling.
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